Zimmerman, B.
and Judge, S.
(2008),
Traceability in Nuclear Medicine, Metrologia
(Accessed December 11, 2024)
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Traceability in Nuclear Medicine
Published
Author(s)
, Steven Judge
Abstract
Accurate, reproducible measurement of radioactivity in nuclear medicine applications is vital to ensuring the safety and effectiveness of disease diagnosis and treatment using unsealed radioactive sources. The need to maintain a high degree of confidence in those measurements requires that they be carried out so as to be traceable to national and international standards. In addition, measurement traceability for radioactivity in medicine helps ensure international consistency in measurement at all levels of practice (national measurement laboratories, research institutions, isotope producers, radiopharmaceutical manufacturers, and clinics). This paper explores the importance of radioactivity measurement in nuclear medicine and demonstrates how traceability can be extended from international standards to the quantity of the drug administered to the patient.Citation
Metrologia
Pub Type
Journals
Keywords
biosystems, helath, medicine, radiopharmaceuticals, traceability
Citation
Issues
If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.
Created October 16, 2008